140 related articles for article (PubMed ID: 15145149)
1. Target repositioning optimization in prostate cancer: is intensity-modulated radiotherapy under stereotactic conditions feasible?
Miralbell R; Mollà M; Arnalte R; Canales S; Vargas E; Linero D; Waters S; Nouet P; Rouzaud M; Escudé L
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):366-71. PubMed ID: 15145149
[TBL] [Abstract][Full Text] [Related]
2. Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy?
Mollà M; Escude L; Nouet P; Popowski Y; Hidalgo A; Rouzaud M; Linero D; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):118-24. PubMed ID: 15850911
[TBL] [Abstract][Full Text] [Related]
3. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer.
Hoogeman MS; van Herk M; de Bois J; Lebesque JV
Radiother Oncol; 2005 Feb; 74(2):177-85. PubMed ID: 15734206
[TBL] [Abstract][Full Text] [Related]
4. Quantification of prostate and seminal vesicle interfraction variation during IMRT.
Frank SJ; Dong L; Kudchadker RJ; De Crevoisier R; Lee AK; Cheung R; Choi S; O'Daniel J; Tucker SL; Wang H; Kuban DA
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):813-20. PubMed ID: 18207664
[TBL] [Abstract][Full Text] [Related]
5. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
6. Impact of geometric uncertainties on evaluation of treatment techniques for prostate cancer.
Craig T; Wong E; Bauman G; Battista J; Van Dyk J
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):426-36. PubMed ID: 15890584
[TBL] [Abstract][Full Text] [Related]
7. Application of dose compensation in image-guided radiotherapy of prostate cancer.
Wu Q; Liang J; Yan D
Phys Med Biol; 2006 Mar; 51(6):1405-19. PubMed ID: 16510952
[TBL] [Abstract][Full Text] [Related]
8. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
[TBL] [Abstract][Full Text] [Related]
9. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
10. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
11. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
12. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?
Sanguineti G; Cavey ML; Endres EJ; Franzone P; Barra S; Parker BC; Marcenaro M; Colman M; Agostinelli S; Foppiano F; Vitale V
Strahlenther Onkol; 2006 Sep; 182(9):543-9. PubMed ID: 16944377
[TBL] [Abstract][Full Text] [Related]
13. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
14. Impact of endorectal balloon in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with IMRT.
Vlachaki MT; Teslow TN; Ahmad S
Med Dosim; 2007; 32(4):281-6. PubMed ID: 17980829
[TBL] [Abstract][Full Text] [Related]
15. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
Hsu A; Pawlicki T; Luxton G; Hara W; King CR
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):898-902. PubMed ID: 17459610
[TBL] [Abstract][Full Text] [Related]
16. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
[TBL] [Abstract][Full Text] [Related]
18. [Constraints and dosage for prostate cancer patients treated with conformal radiotherapy and intensity modulated radiation therapy].
Chauvet I; Gaboriaud G; Pontvert D; Zefkili S; Giraud P; Rosenwald JC; Cosset JM
Cancer Radiother; 2004 Dec; 8(6):337-51. PubMed ID: 15619378
[TBL] [Abstract][Full Text] [Related]
19. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
